Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients-Reference-Cited by-同舟云学术

Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients

Published:2018-01-11 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

De Monte Ariella¹,Brunetti Davide²,Cattin Luigi²,Lavanda Francesca²,Naibo Erica²,Malagoli Maria³,Stanta Giorgio²,Bonin Serena²

Affiliation:

1. Unit of Medical Clinic, University Hospital of Cattinara-ASUITS, I‑34149 Trieste, Italy

2. Department of Medical Sciences, University of Trieste, Cattinara Hospital, I‑34149 Trieste, Italy

3. Oncology Unit, University Hospital of Cattinara-ASUITS, I‑34149 Trieste, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on PI3KCA-Mutant Colorectal Cancer Cells;International Journal of Molecular Sciences;2024-05-15

2. A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2024-05

3. Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases;Molecular Nutrition & Food Research;2024-03-20

4. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study;Journal of International Medical Research;2023-04

5. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics;Seminars in Cancer Biology;2021-01